Anti-hypertensive refers to substances or treatments that are used to lower high blood pressure. Hypertension, or high blood pressure, is a common condition where the force of blood against the walls of the arteries is consistently too high. Over time, untreated hypertension can lead to serious health problems such as heart disease, stroke, and kidney disease.
Anti-hypertensive medicinal plants work to help lower blood pressure and reduce the risk of complications associated with hypertension. These herbs may act on the heart, blood vessels, or kidneys to decrease blood pressure.
In South Africa’s traditional medicine a number of plants are used to address blood pressure, below is a list of herbs extracted from the research paper “A Review of Plants Used in South African Traditional Medicine for the Management and Treatment of Hypertension”, that are useful for hypertension.
Research Paper: A Review of Plants Used in South African Traditional Medicine for the Management and Treatment of Hypertension
Authors: Fatai Oladunni Balogun, Anofi Omotayo Tom Ashafa
Published: Published online November 26, 2018 | Planta Med 2019
Table 2 Medicinal Plants with Reported Anti-hypertensive Activity
Name | Pharmacological activities | Pharmacological activities | Pharmacological activities | Assay | Method(s)/ inducing agent | Part(s) used | Medium for extraction | Conc. tested | Province(s) or location | References |
---|---|---|---|---|---|---|---|---|---|---|
Antioxidant, | Antidiabetic | Antihypertensive, type(s) cardiovascular | ||||||||
Acokanthera oppositifolia | Antioxidant | In vitro | DPPH, ABTS, FRAP | Stem | Methanol | 0.1 mg/mL | Eastern Cape | [112] | ||
Adenopodia spicata | Antihypertensive | In vitro | ACEI assay | Leaves, root | Aqueous, ethanol | 25 µg/mL | KZN | [34] | ||
Aganpanthus africanus | Antihypertensive | In vitro | ACEI assay | Leaves, root | Aqueous | 25 µg/mL | KZN | [34] | ||
Agathosma betulina | Antioxidant | In vitro | ABTS, DPPH | Leaves | Hot water, DCM | 1, 3, 5, 10, 20 µg/mL | Pretoria | [113] | ||
Antidiabetic | In vitro | α-amylase, α-glucosidase | ||||||||
Antioxidant | In vivo | ORAC, TEAC, FRAP | Aqueous, ethanol, acetone | Cape Town | [114] | |||||
Agave americana | Antihypertensive | In vitro | ACEI assay | Leaves | Aqueous, ethanol | 25 µg/mL | KZN | [34] | ||
Alepidea amatymbica | Antihypertensive, cardiovascular, diuretic | In vivo | Sodium thiopentone (rats model) | Rhizome | Hexane, methanol, DCM | 20 mg/kg body weight | KZN | [38, 115] | ||
Amaranthus dubius | Antihypertensive | In vitro | ACEI | Leaves | Aqueous, methanol | 0.1 g/mL | KZN | [18] | ||
Amaranthus hybridus | ACE inhibitory activity | In vitro | ACEI | Leaves | Aqueous, methanol | 0.1 g/mL | KZN | [18] | ||
Artemisia afra | Antidiabetic | In vivo | STZ-induced rat model | Leaves | Aqueous | 50, 100, 200 mg/kg | Eastern Cape | [116] | ||
Cardioprotection | In vivo | ISP | Leaves | Aqueous | 100, 200 mg/kg | Eastern Cape | [117] | |||
Asystasia gangetica | Antihypertensive | In vitro and | ACEI | Leaves | Aqueous and methanol | 0.1 g/mL | KZN | [18] | ||
In vivo | Sodium pento- barbitone | Aqueous | 10, 25, 50, 100, 200, 400 mg/mL | Western Cape | [46] | |||||
Carpobrotus dimidiathus | Antioxidant | In vitro | DPPH, FRAC | Leaves | Aqueous methanol (50 %) | 10, 20, 30, 40, 50, 60, 70 µg/mL | KZN | [108] | ||
Catha edulis | Antihypertensive | In vitro | ACEI assay | Leaves | Aqueous, ethanol | 25 µg/mL | KZN | [34] | ||
Citrus lemon | Antioxidant | In vitro | DPPH, nitric oxide, reducing power, | Peel of fruits | Ethanol, acetone | 0.025, 0.05, 0.1, 0.2, 0.5 ug/mL | Eastern Cape | [54] continued |
||
Clausena anisata | Antihypertensive | In vivo | HRM | Leaves | Aqueous | 50, 100, 200, 400 mg/bw | Limpopo | [59] | ||
Antidiabetic | In vivo | STZ- rat model | Roots | Methanol | 100, 200, 400, 800 mg/kg bw | KZN | [58] | |||
Crinum macowani | Cardiovascular | In vivo | Normotensive rats | Whole plants | Aqueous | 0.05, 0.10, 0.15, 0.20 mg/kg | Western Cape | [62–63] | ||
Dicoma anomala | Antioxidant | Antidiabetic | In vivo | STZ-rat model | Root | Aqueous | 125, 250, 500 mg/kg | Free State | [118] | |
Cardioprotection | In vivo | ISP‑rat | Root | Aqueous | same | Same | [119] | |||
Dietes iridioides | Antihypertensive | In vitro | ACEI assay | Leaves, root | Aqueous | 25 µg/mL | KZN | [34] | ||
Dombeya rotundifolia | Antihypertensive | In vitro | ACEI assay | Leaves, root | Aqueous | 25 µg/mL | KZN | [34] | ||
Ekeberghia capensis | Cardiovascular, vasorelaxant, bradycardia | In vivo | Inactin- induced normoten- sive rats and Dahl salt stress rats | Leaves | Ethanol | 18 mg/kg i. v. and 120 mg/kg p.o | KZN | [120] | ||
Euclea undulata | Hypoglycemic | In vitro | α-amylase, α-gluco- sidase, glucose uptake (GU) | Whole plant | Acetone | 50 µg/mL and 16–250 µg/mL GU | Gauteng (Pretoria) | [120] | ||
In vivo | STZ-rat model | Bark | Acetone | 50, 100 mg/kg b.w | Gauteng (Pretoria) | [121] | ||||
Hypoxis hemerocallidea | Cardiovascular, anti- hypertensive | In vitro | Isolated muscle experiment | Fresh corm | Aqueous | 12.5, 25, 50, 100, 200, 400 mg/mL | KZN | [75] | ||
In vivo | Sodium 5-ethyl- (1-methylbutyl)-2- thiobarbiturate- induced Dahl salt- stress rats | As above | Same as above | 25, 50, 100, 200, 400 mg/kg b.w | KZN | [75] | ||||
Justicia flava | Antihypertensive | In vitro | ACEI assay | Leaves | Aqueous, methanol | 0.1 g/mL | KZN | [18] | ||
Pentanissia prunelloides | Antioxidant | In vitro | DPPH, Superoxide anion, Hydroxyl radical, Metal chelating | Root | Aqueous, ethanol, hydro-ethanol (1 : 1), hexane | 6.25, 12.5, 25, 50, 100 µg/mL | Free State | [129] | ||
Antidiabetic | In vitro | Alpha (amylase and glucosidase) | ||||||||
Physalis viscosa | Antihypertensive | In vitro | ACEI | Leaves | Methanol, aqueous | 0.1 g/mL | KZN | [18] | ||
Protorhus longifolia | Antioxidant | In vitro | DPPH, ABTS, metal chelating, Reducing power | Bark | Hexane, chlorofum, ethyl acetate, methanol, aqueous | 0–5 mg/100 mL | KZN | [89] | ||
Antihypertensive | In vitro | ACEI | Leaves | Aqueous, ethanol | 25 µg/mL | KZN | [34] | |||
Psidium guaįava | Hypoglycemic | Hypotensive | In vivo | STZ-induced rats and Dahl salt-stress rats | Leaves | Aqueous | 50, 100, 200, 400, 800 mg/mL | KZN | [93] | |
Rauvolfia caffra | Antioxidant | In vitro | FRAP, DPPH, | Stem, bark | DCM, methanol, ethyl acetate, ethanol | 1 mg/mL | Limpopo | [96] | ||
Antihypertensive | In vivo | Spontaneously hypertensive rats | Whole plants | DCM, methanol, ethyl acetate | 15, 300, 500 mg/kg b.w | |||||
Rhus chirindensis | Antihypertensive | In vitro | ACEI | Leaves | Aqueous, ethanol | 25 µg/mL | KZN | [34] | ||
Sclerocarya birrea | Hypoglycemic | In vivo | STZ | Stem-bark | Aqueous | 25, 50, 100, 200, 400, 800, 1600 mg/mL | KZN | [100] | ||
Antihypertensive | In vitro | ACEI | Leaves | Aqueous, ethanol | 25 µg/mL | KZN | [34, 101] | |||
In vivo | Dahl salt sensitive rats | Stem bark | Aqueous | 25, 50, 100, 200, 400 mg/mL | KZN | |||||
Senecio serratulloides | Antioxidant | In vitro | DPPH, FRAC | Leaves | Aqueous methanol (50 %) | 10, 20, 30, 40, 50, 60, 70 µg/mL | KZN | [112] | ||
Stangeria eriopus | Antihypertensive | In vitro | ACEI | Leaves | Aqueous, ethanol | 25 µg/mL | KZN | [34] | ||
Trichilia emetica | Antioxidant | In vitro | DPPH | leaves | Aqueous, methanol | Gauteng | [130] |
ACEI: angiotensin converting enzyme inhibitor; STZ: streptozotocin; ABTS: 2, 2-azino-bis (3-ethylbenzothiazoline-6)-sulphonic acid; DPPH: 1,1-diphenyl-2-picryl hydrazyl; FRAC: ferrous-reducing antioxidant capacity;
ORAC: oxygen radical absorbance capacity; TEAC: Trolox equivalent antioxidant capacity; ISP: isoproterenol; DCM: dichloromethane; KZN: KwaZulu-Natal
Reference:
Fatai Oladunni Balogun, Anofi Omotayo Tom Ashafa: A Review of Plants Used in South African Traditional Medicine for the Management and Treatment of Hypertension – Published online: 2018-11-26
This article is copyrighted by Ital is Vital, 2024. Want to re-post this article? Visit our guidelines.
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. The purpose of this website is to promote broad consumer understanding and knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.